Royal Bank Of Canada Purple Biotech Ltd. Transaction History

Royal Bank Of Canada

  • $471 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$0.58 - $0.92 $1,247 - $1,978
2,150 Added 26875.0%
2,158 $1,000
Q4 2023

Feb 14, 2024
SELL
$0.78 - $1.67 $78 - $167
-100 Reduced 92.59%
8 $0
Q1 2022

May 16, 2022
BUY
$2.45 - $4.3 $264 - $464
108 New
108 $0

Others Institutions Holding PPBT

# of Institutions
1
Shares Held
15
Call Options Held
0
Put Options Held
0
View Full List

About PURPLE BIOTECH LTD.

PPBT Quotes by TradingView
  • Ticker PPBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 18,303,300
  • Market Cap $67M
  • Description
  • Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug for cancer patients in the United States. Its oncology pipeline includes CM24, a monoclonal antibody that blocks carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhi...
More about PPBT
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email